Adverse effects of iodine thyroid blocking: A systematic review

Radiation Protection Dosimetry

Volumn 150, Issue 3, 2012, Pages 267-277

  Spallek, L ^a   Krille, L ^b   Reiners, C ^c   Schneider, R ^c   Yamashita, S ^d   Zeeb, H ^a,b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM IODIDE;

ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; HUMAN; LITERATURE; THYROID DISEASE; THYROID TUMOR;

CASE-CONTROL STUDIES; HUMANS; POTASSIUM IODIDE; REVIEW LITERATURE AS TOPIC; THYROID DISEASES; THYROID NEOPLASMS;

EID: 84864105701     PISSN: 01448420     EISSN: 17423406     Source Type: Journal    
DOI: 10.1093/rpd/ncr400     Document Type: Article

References (50)

1. Kazakov, V. S., Demidchik, E. P. and Astakhova, L. N. Thyroid cancer after Chernobyl. Nature 359(6390), 21 (1992).
2. Stsjazhko, V. A., Tsyb, A. F., Tronko, N. D., Souchkevitch, G. and Baverstock, K. F. Childhood thyroid cancer since accident at Chernobyl. Br Med J 310(6982), 801 (1995).
3. Likhtarev, I. A., Sobolev, B. G., Kairo, I. A., Tronko, N. D., Bogdanova, T. I., Oleinic, V. A., Epshtein, E. V. and Beral, V. Thyroid cancer in the Ukraine. Nature 375(6530), 365 (1995).
4. Astakhova, L. N. et al. Chernobyl-related thyroid cancer in children of Belarus: a case-control study. Radiat. Res. 150(3), 349-356 (1998).
5. Jacob, P. et al. Thyroid cancer risk to children calculated. Nature 392(6671), 31-32 (1998).
6. Heidenreich, W. F., Kenigsberg, J., Jacob, P., Buglova, E., Goulko, G., Paretzke, H. G., Demidchik, E. P. and Golovneva, A. Time trends of thyroid cancer incidence in Belarus after the Chernobyl accident. Radiat. Res. 151(5), 617-625 (1999).
7. Le Guen, B., Stricker, L. and Schlumberger, M. Distributing KI pills to minimize thyroid radiation exposure in case of a nuclear accident in France. Nat. Clin. Pract. Endocrinol. Metab. 3(9), 611 (2007).
8. Jang, M., Kim, H. K., Choi, C. W. and Kang, C. S. Age-dependent potassium iodide effect on the thyroid irradiation by 131I and 133I in the nuclear emergency. Radiat. Prot. Dosim. 130(4), 499-502 (2008).
9. Nauman, J. and Wolff, J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am. J. Med. 94, 524-532 (1993).
10. Lind, P., Langsteger, W., Molnar, M., Gallowitsch, H. J., Mikosch, P. and Gomez, I. Epidemiology of thyroid diseases in iodine sufficiency, Thyroid 8(12), 1179-1183 (1998).
11. Lind, P., Kumnig, G., Heinisch, M., Igerc, I., Mikosch, P., Gallowitsch, H. J., Kresnik, E., Gomez, I., Unterweger, O. and Aigner, H. Iodine supplementation in Austria: methods and results. Thyroid 12(10), 903-907 (2002).
12. Baverstock, K., Blomqvist, L., Klein, G., Paile, W. and Repacholi, M. Guidelines for Iodine Prophylaxis Following Nuclear Accidents. WHO (1999).
13. Canada vigilance online database. Available on: http://www.hc-sc.gc.ca/dhp-mps/medeff/databasdon/indexeng. php (2010).
14. Database of Select Committee on GRAS Substances (SCOGS) Reviews. Available on:http://www.fda.gov/ Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASSubstancesSCOGSDatabase/default.htm (2009). U.S.Food and Drug Administration (FDA).
15. Howick, J., Philips, B., Ball, B., Sackett, D., Badenoch, D., Straus, S., Haynes, B. and Dawes, M. Oxford centre for evidence-based medicine levels of evidence (March 2009). http://www.cebm.net/index.aspx?o=1025 (2009).
16. Mahomed, K. and Gulmezoglu, A. M. Maternal iodine supplements in areas of deficiency. Cochrane Database Syst. Rev. (3), CD000135 (2006).
17. Curd, J.G., Milgrom, H., Stevenson, D. D., Mathison, D. A. and Vaughan, J. H. Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis. Ann. Intern. Med. 91(6), 853-857 (1979).
18. Stewart, J. C. and Vidor, G. I. Thyrotoxicosis induced by iodine contamination of food-a common unrecognised condition?. Br. Med. J. 1(6006), 372-375 (1976).
19. Johnson, T. M. and Rapini, R. P. The Wolff-Chaikoff effect: hypothyroidism due to potassium iodide. Arch. Dermatol. 124(8), 1184-1185 (1988).
20. Becker, D. V., Braverman, L. E., Dunn, J. T., Gaitan, E., Gorman, C., Maxon, H., Schneider, A. B., Vanmiddlesworth, L. and Wolff, J. The use of iodine as a thyroidal blocking-agent in the event of a reactor accident- report of the environmental Hazards Committee of the American-Thyroid-Association. J. Am. Med. Assoc. 252(5), 659-661 (1984).
21. Becker, D. V. Reactor accidents. Public health strategies and their medical implications. J. Am. Med. Assoc. 258(5), 649-654 (1987).
22. Becker, D. V. and Zanzonico, P. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid 7(2), 193-197 (1997).
23. Crocker, D. G. Nuclear reactor accidents-the use of KI as a blocking agent against radioiodine uptake in the thyroid-a review. Health Phys. 46(6), 1265-1279 (1984).
24. Yalow, R. S. Risks in mass distribution of potassium iodide. Bull. N.Y. Acad. Med. 59(10), 1020-1027 (1983).
25. Sterling, J. B. and Heymann, W. R. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J. Am. Acad. Dermatol. 43(4), 691-697 (2000).
26. Verger, P., Aurengo, A., Geoffroy, B. and Le, G. B. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: a review. Thyroid 11(4), 353-360 (2001).
27. Sicherer, S.H. Risk of severe allergic reactions from the use of potassium iodide for radiation emergencies. J. Allergy Clin. Immunol. 114(6), 1395-1397 (2004).
28. British National Radiological Protection Board (NRPB). NRPB response to Working Group Report on stable iodine prophylaxis. 1880. NRPB (2001).
29. Hosoya, T., Yamaguchi, K., Akutsu, T., Mitsuhashi, Y., Kondo, S., Sugai, Y. and Adachi, M. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat. Med. 18(1), 39-45 (2000).
30. Takamura, N., Nakamura, Y., Ishigaki, K., Ishigaki, J., Mine, M., Aoyagi, K. and Yamashita, S. Thyroid blockade during a radiation emergency in iodine-rich areas: effect of a stable-iodine dosage. J. Radiat. Res. (Tokyo) 45(2), 201-204 (2004).
31. Giovannelli, G. Radioiodine and thyroid carcinoma: KI prophylaxis in children. Acta Biomed. 75(2), I-XIII (2004).
32. Zanzonico, P. B. and Becker, D. V. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys. 78(6), 660-667 (2000).
33. Angermayr, L. and Clar, C. Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database Syst. Rev. (2), CD003819 (2004).
34. UK Working Group on Stable Iodine Prophylaxis. Stable iodine prophylaxis. Recommendations of the 2nd UK Working Group on Stable Iodine Prophylaxis. Documents of the National Radiological Protection Board (NRPB). 12(3) (2001).
35. Chow, C. C., Phillips, D. I., Lazarus, J. H. and Parkes, A. B. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable?. Clin. Endocrinol. (Oxf) 34(5), 413-416 (1991).
36. Galofre, J. C., Fernandez-Calvet, L., Rios, M. and Garcia-Mayor, R. V. Increased incidence of thyrotoxicosis after iodine supplementation in an iodine sufficient area. J. Endocrinol. Invest. 17(1), 23-27 (1994).
37. Laurberg, P., Pedersen, K. M., Vestergaard, H. and Sigurdsson, G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J. Int. Med. 229(5), 415-420 (1991).
38. Li, M. et al. Endemic goitre in central China caused by excessive iodine intake. Lancet 2(8553), 257-259 (1987).
39. Mazziotti, G. et al Evolution of thyroid autoimmunity during iodine prophylaxis-the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103-110 (2003).
40. McMonigal, K. A., Braverman, L. E., Dunn, J. T., Stanbury, J. B., Wear, M. L., Hamm, P. B., Sauer, R. L., Billica, R. D. and Pool, S. L. Thyroid function changes related to use of iodinated water in the U.S. Space Program. Aviat. Space Environ. Med. 71(11), 1120-1125 (2000).
41. Minelli, R., Braverman, L. E., Giuberti, T., Schianchi, C., Gardini, E., Salvi, M., Fiaccadori, F., Ugolotti, G. and Roti, E. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferonalpha treatment. Clin. Endocrinol. (Oxf) 47(3), 357-361 (1997).
42. Nagata, K., Takasu, N., Akamine, H., Ohshiro, C., Komiya, I., Murakami, K., Suzawa, A. and Nomura, T. Urinary iodine and thyroid antibodies in Okinawa, Yamagata, Hyogo, and Nagano, Japan: the differences in iodine intake do not affect thyroid antibody positivity. Endocr. J. 45(6), 797-803 (1998).
43. Paul, T., Meyers, B., Witorsch, R. J., Pino, S., Chipkin, S., Ingbar, S. H. and Braverman, L. E. The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism 37(2), 121-124 (1988).
44. Roti, E., Gardini, E., Minelli, R., Bianconi, L., Salvi, M., Gavaruzzi, G. and Braverman, L. E. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 76(4), 928-932 (1993).
45. Todd, C. H. and Dunn, J. T. Intermittent oral administration of potassium iodide solution for the correction of iodine deficiency. Am. J. Clin. Nutr. 67(6), 1279-1283 (1998).
46. Zimmermann, M. B., Moretti, D., Chaouki, N. and Torresani, T. Introduction of iodized salt to severely iodine-deficient children does not provoke thyroid autoimmunity: a one-year prospective trial in northern Morocco. Thyroid 13(2), 199-203 (2003).
47. Zimmermann, M. B., Ito, Y., Hess, S. Y., Fujieda, K. and Molinari, L. High thyroid volume in children with excess dietary iodine intakes. Am. J. Clin. Nutr. 81(4), 840-844 (2005).
48. Solanki, K. K., Bomanji, J. B., Waddington, W. A. and Ell, P. J. Thyroid blocking policy-revisited. Nucl. Med. Commun. 25(11), 1071-1076 (2004).
49. Richardson, D.B. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 20(2), 181-187 (2009).
50. Derry, S., Loke, Y. K. and Aronson, J. K. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. Med. Res. Methodol. 1, 7 (2001).